Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00934622 · ClinicalTrials.gov registry record · Phase 4
Visual Function After Implantation of Bilateral AcrySoft ReSTOR Aspheric IOL
A Phase 4 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 76
- Enrollment target
NCT00934622 is a Phase 4 study that has completed, run by Alcon Research. The registered enrollment target is 76 participants.
The verdict
NCT00934622, a Phase 4 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 76 participants
- Enrollment target
Study Summary
This study will involve up to 20 bilateral patients per surgeon. Patients will be assessed pre-operatively, and at subsequent visits (following the implantation of the intraocular lens in the second eye) at 1 week, 1 month, 3 months and 6 months post-operatively.
Interventions
- DEVICE AcrySof® ReSTOR® Aspheric IOL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2007-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00934622
The ClinicalTrials.gov registry entry for NCT00934622 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AcrySof® ReSTOR® Aspheric IOL is the first listed.
NCT00934622 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00934622 about?
NCT00934622 is a clinical study titled "Visual Function After Implantation of Bilateral AcrySoft ReSTOR Aspheric IOL". This study will involve up to 20 bilateral patients per surgeon. Patients will be assessed pre-operatively, and at subsequent visits (following the implantation of the intraocular lens in the second eye) at 1 week, 1 month, 3 months and 6 months post-operatively.
What is the current status of trial NCT00934622?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 76 participants. The study started on 2007-11.
What interventions are being tested in trial NCT00934622?
The interventions under investigation include: AcrySof® ReSTOR® Aspheric IOL (DEVICE).
Who is sponsoring clinical trial NCT00934622?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.